Home › Glaucoma › NCT03933631
Pilocarpine Use After Kahook Goniotomy
RecruitingPhase 3
A Prospective Randomized Control Trial of Pilocarpine Use After Combined Cataract/Kahook Dual Blade Surgery
Who can join
Ages 30 to 100 · All sexes
Full eligibility criteria
Inclusion Criteria: * Patients with ocular hypertension or open angle glaucoma undergoing combined cataract surgery with KDB in a single surgical center at Montefiore Medical Center with a single provider Exclusion Criteria: * Patients with previous history of eye surgeries (including laser procedures)
About the study
The goal of this study is to determine whether using pilocarpine provides added benefit to the success of combined cataract + Kahook Dual Blade (KDB) surgery.
What is being tested
- Pilocarpine (drug)
- Prednisolone (drug)
- Ofloxacin (drug)
Sponsor: Montefiore Medical Center · Participants: 142 · Started: May 1, 2019
Contact the study team
- Wen-Jeng (Melissa) Yao, MD · Phone: 718-920-2020
Official record on ClinicalTrials.gov — NCT03933631
Locations in the U.S.
| New York | Montefiore Medical Center, The Bronx Montefiore Wakefield Campus, The Bronx |
Conditions
From ClinicalTrials.gov, data retrieved Sep 30, 2026. Each study sets its own eligibility; the study team decides who can join.